Abstract
Teledermatology is a form of telemedicine that has enabled the rapid delivery of dermatologic care in multiple countries. According to the 2015 global survey on eHealth by the World Health Organization, 46% of 125 countries indicated that some type of teledermatology service was being offered to citizens. This is up from 38% out of 114 responding countries from the previous 2009 global eHealth survey. While teledermatology utilization has generally increased worldwide due to the novel COVID-19 pandemic, variations in country-specific adoption and implementation have been observed. Differences in healthcare regulations, technology infrastructure, and cultural attitudes towards alternative healthcare delivery models compared to conventional face-to-face visits have dramatically shaped teledermatology practices internationally. In this chapter, we provide a rigorous overview of the international teledermatology landscape, emphasizing the history and current usage of teledermatology in non-US developed countries.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Karimkhani C, Dellavalle RP, Coffeng LE, et al. Global skin disease morbidity and mortality. JAMA Dermatol. 2017;153(5):406–12.
Seth D, Cheldize K, Brown D, Freeman EE. Global burden of skin disease: inequities and innovations. Curr Derm Rep. 2017;6(3):204–10.
Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ, et al. The global burden of skin disease in 2010: An analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2014;134(6):1527–34.
Atlas of eHealth country profiles: the use of eHealth in support of universal health coverage [Internet]. [cited 2022 Jun 14]. https://www.who.int/publications-detail-redirect/9789241565219
WHO Global Observatory for eHealth. Telemedicine: opportunities and developments in Member States: report on the second global survey on eHealth [Internet]. World Health Organization; 2010 [cited 2022 Jun 14]. https://apps.who.int/iris/handle/10665/44497
Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91(1):157–60.
Farr MA, Duvic M, Joshi TP. Teledermatology during COVID-19: An updated review. Am J Clin Dermatol. 2021;22(4):467–75.
Perkins S, Cohen JM, Nelson CA, Bunick CG. Teledermatology in the era of COVID-19: experience of an academic department of dermatology. J Am Acad Dermatol. 2020;83(1):e43–4.
Rismiller K, Cartron AM, Trinidad JCL. Inpatient teledermatology during the COVID-19 pandemic. J Dermatol Treat. 2020;31(5):441–3.
Kennedy J, Arey S, Hopkins Z, Tejasvi T, Farah R, Secrest AM, et al. Dermatologist perceptions of teledermatology implementation and future use after COVID-19: demographics, barriers, and insights. JAMA Dermatol. 2021;157(5):595–7.
US Centers for Disease Control and Prevention. Using telehealth to expand access to essential health services during the COVID-19 pandemic. Updated June 10, 2020. https://www.cdc.gov/coronavirus/2019-ncov/hcp/telehealth.html. Accessed 14 June 2022.
Bhargava S, McKeever C, Kroumpouzos G. Impact of COVID-19 pandemic on dermatology practices: results of a web-based, global survey. Int J Women’s Dermatol. 2021;7(2):217–23.
Coates SJ, Kvedar J, Granstein RD. Teledermatology: from historical perspective to emerging techniques of the modern era: part I: history, rationale, and current practice. J Am Acad Dermatol. 2015;72(4):563–74.
Alberto C, Raghav S, Abodunde Bukola JM. Use of teledermatology to improve dermatological access in rural areas. Telemed E J Health. 2019;25(11):1022–32. https://www.liebertpub.com/doi/10.1089/tmj.2018.0130
Nations U. Human Development Index [Internet]. Human Development Reports. United Nations; [cited 2022 Jun 14]. https://hdr.undp.org/data-center/human-development-index
UNDP (United Nations Development Programme). The HDI 2010: new controversies, old critiques. New York; 2011.
Şenel E, Demir E. A global productivity and bibliometric analysis of telemedicine and teledermatology publication trends during 1980–2013. Dermatol Sin. 2015;33(1):16–20.
Şenel E, Demir E, Artüz RF. Bibliometric evaluation of global productivity of teledermatology publications between 1975 and 2017 with a 3-year update. Indian J Dermatol. 2018;63(5):437–9.
Telemedicine Position Statement [Internet]. Canadian Dermatology Association. [cited 2022 Jun 16]. https://dermatology.ca/dermatologists/guidelines/position-statements/
Horwood C. Telehealth Options by Province June 2022 | Finder Canada [Internet]. finder CA. 2020 [cited 2022 Jun 16]. https://www.finder.com/ca/telehealth
Provincial Telehealth Resources: An Interactive Map of Canada [Internet]. Benefits by Design 2019 [cited 2022 Jun 16]. https://www.bbd.ca/blog/telehealth-resources-canada/
College of Physicians and Surgeons of New Brunswick—Regulation #13: Telemedicine Regulation [Internet]. [cited 2022 Jun 16]. https://cpsnb.org/en/medical-act-regulations-and-guidelines/regulations/419-regulation-13-telemedicine-regulation.
The Practice of Telemedicine [Internet]. [cited 2022 Jun 16]. https://www.cps.sk.ca/imis/CPSS/Legislation__ByLaws__Policies_and_Guidelines/Legislation_Content/Policies_and_Guidelines_Content/The_Practice_of_Telemedicine.aspx
eConsult for Primary Care | Get Specialist Advice Quickly [Internet]. OTN.ca. [cited 2022 Jun 16]. https://www-origin.otn.ca/providers/primary-care/econsult/
An Analysis of Telemedicine Experiences and Services in Chile | IntechOpen [Internet]. [cited 2022 Jun 16]. https://www.intechopen.com/chapters/65236
How is telehealth regulated? in Argentina—DLA Piper Telehealth Around the World [Internet]. [cited 2022 Jun 16]. https://www.dlapiperintelligence.com/telehealth/countries/index.html?t=02-regulation-of-telehealth&c=AR
Nación presentó el nuevo servicio Tele-Covid para hacer consultas con especialistas en forma remota [Internet]. Argentinagobar 2020 [cited 2022 Jun 16]. https://www.argentina.gob.ar/noticias/nacion-presento-el-nuevo-servicio-tele-covid-para-hacer-consultas-con-especialistas-en
BOLETIN OFICIAL REPUBLICA ARGENTINA—SALUD—Ley 27553 [Internet]. [cited 2022 Jun 16]. https://www.boletinoficial.gob.ar/detalleAviso/primera/233439
MOH | Listing of Direct Telemedicine Providers: Transition Approach Prior to Licensing Under the Healthcare Services Act (HCSA) [Internet]. [cited 2022 Jun 16]. https://www.moh.gov.sg/licensing-and-regulation/telemedicine
MOH | Time-limited Extension of CHAS Subsidy and Use of MediSave for Follow up of Chronic Conditions through Video Consultations in view of COVID-19 [Internet]. [cited 2022 Jun 16]. https://www.moh.gov.sg/covid-19/vc
Janardhanan L, Leow YH, Chio MT, Kim Y, Soh CB. Experience with the implementation of a web-based teledermatology system in a nursing home in Singapore. J Telemed Telecare. 2008;14(8):404–9.
Som MHM, Norali AN, Ali MSAM. Telehealth in Malaysia—An overview. In: 2010 IEEE Symposium on Industrial Electronics and Applications (ISIEA). 2010. p. 660–4.
Ng SW, Hwong WY, Husin M, Rahman NA, Nasir NH, Juval K, et al. Assessing the availability of teleconsultation and the extent of its use in Malaysian public primary care clinics: cross-sectional study. JMIR Form Res. 2022;6(5):e34485.
Cai H, Wang H, Guo T, Bao G. Application of telemedicine in Gansu Province of China. PLoS One. 2016;11(6):e0158026.
Wang TT, Li JM, Zhu CR, Hong Z, An DM, Yang HY, et al. Assessment of utilization and cost-effectiveness of telemedicine program in Western regions of China: a 12-year study of 249 hospitals across 112 cities. Telemed J E Health. 2016;22(11):909–20.
Xu W, Pan Z, Lu S, Zhang L. Regional heterogeneity of application and effect of telemedicine in the primary care Centres in Rural China. Int J Environ Res Public Health. 2020;17(12):4531.
He C, Zhou Q, Chen W, Tian J, Zhou L, Peng H, et al. Using an internet-based hospital to address maldistribution of health care resources in rural areas of Guangdong Province, China: retrospective and descriptive study. JMIR Med Inform. 2018;6(4):e51.
Cui Y. Telemedicine and AI for dermatology care in China, presentation 8th World Congress, Int Soc Teledermatol, 5–6 November, 2020.
Zheng Y, Lin Y, Cui Y. Teledermatology in China: history, current status, and the next step. J Investig Dermatol Symp Proc. 2018;19(2):S71–3.
Li CX, Shen CB, Xue K, Shen X, Jing Y, Wang ZY, et al. Artificial intelligence in dermatology: past, present, and future. Chin Med J. 2019;132(17):2017–20.
Han Y, Lie RK, Guo R. The internet hospital as a telehealth model in China: systematic search and content analysis. J Med Internet Res. 2020;22(7):e17995.
Mu Z, Liu X, Li K, Zhang J. Teledermatology service during the COVID-19 pandemic in China: a mobile application-based retrospective study. CCID. 2021;14:1119–24.
Yong-Jeon C. A comparative study on the telemedicine law pre and post-COVID-19 pandemic; comparison analysis between Korea, and the US. Am J Bioinform Res. 2021;11(2):49–58.
Kim HS, Kim B, Lee SG, Jang SY, Kim TH. COVID-19 case surge and telemedicine utilization in a tertiary hospital in Korea. Telemed J EHealth. 2022;28(5):666–74.
Seol JE, Park SH, Kim H. Analysis of live interactive teledermatologic consultations for prisoners in Korea for 3 years. J Telemed Telecare. 2018;24(9):623–8.
Shin H, Kim DH, Ryu HH, Yoon SY, Jo SJ. Teledermatology consultation using a smartphone multimedia messaging service for common skin diseases in the Korean army: a clinical evaluation of its diagnostic accuracy. J Telemed Telecare. 2014;20(2):70–4.
Demiya-Dillenburger S, Isshiki M, Mahlich J. Telemedicine in Japan: challenges and opportunities. In: Walzer S, editor. Digital Healthcare in Germany: Market Access for Innovations [Internet]. Cham: Springer; 2022 [cited 2022 Jun 17]. p. 85–95. (Contributions to Economics). https://doi.org/10.1007/978-3-030-94025-6_8
Ashique KT, Kaliyadan F. Teledermatology in the wake of COVID -19 scenario: An Indian perspective. Indian Dermatol Online J. 2020;11(3):301–6.
Dinakaran D, Manjunatha N, Kumar CN, Math SB. Telemedicine practice guidelines of India, 2020: implications and challenges. Indian J Psychiatry. 2021;63(1):97–101.
IMAJ | The Israel Medicine Association Journal | Volume, Number 8, August 2005 | Teledermatology: Quality Assessment by User Satisfaction and Clinical Efficiency [Internet]. [cited 2022 Jun 17]. https://www.ima.org.il/MedicineIMAJ/viewarticle.aspx?year=2005&month=08&page=487
Barayev E, Shental O, Yaari D, Zloczower E, Shemesh I, Shapiro M, et al. WhatsApp tele-medicine—usage patterns and physicians views on the platform. Isr J Health Policy Res. 2021;10(1):34.
Telemedicine—The Official Portal of the UAE Government [Internet]. [cited 2022 Jun 17]. https://u.ae/en/information-and-services/health-and-fitness/telemedicine
Digital T. Remote Healthcare Platform | Department of Health Abu Dhabi [Internet]. [cited 2022 Jun 17]. https://www.doh.gov.ae/en/covid-19/Remote-Healthcare-Platform
MedX Health Corp. and Al Zahrawi Medical Supplies LLC Announce Distribution Agreement for Leading-Edge Teledermatology Screening Platform in United Arab Emirates [Internet]. 2021 [cited 2022 Jul 11]. https://www.businesswire.com/news/home/20211118006346/en/MedX-Health-Corp.-and-Al-Zahrawi-Medical-Supplies-LLC-Announce-Distribution-Agreement-for-Leading-Edge-Teledermatology-Screening-Platform-in-United-Arab-Emirates
Alakeel A. Acceptance of teledermatological practices: a cross-sectional study of practicing Saudi dermatologists. Cureus. 2021;13(3):e13710.
Temiz SA, Dursun R, Daye M, Ataseven A. Evaluation of dermatology consultations in the era of COVID-19. Dermatol Ther. 2020;33(5):e13642.
Altunisik N, Turkmen D, Calikoglu E, Sener S. Views and experiences of dermatologists in Turkey regarding teledermatology during the COVID-19 pandemic. J Cosmet Dermatol. 2020;19(10):2460–3. https://doi.org/10.1111/jocd.13677.
Lim AC, Egerton IB, Shumack SP. Australian teledermatology: the patient, the doctor and their government. Australas J Dermatol. 2000;41(1):8–13.
Byrom L, Lucas L, Sheedy V, Madison K, McIver L, Castrisos G, Alfonzo C, Chiu F, Muir J. Tele-Derm national. Aust J Rural Health. 2016;24:193–9.
Muir J, Lucas L. Tele-dermatology in Australia. Stud Health Technol Inform. 2008;131:245–53.
Biscak TM, Eley R, Manoharan S, Sinnott M, Soyer HP. Audit of a state-wide store and forward teledermatology service in Australia. J Telemed Telecare. 2013;19(7):362–6.
See A, Lim AC, Le K, See J-A, Shumack SP. Operational teledermatology in Broken Hill, rural Australia. Australas J Dermatol. 2005;46:144–9.
Low ZM, Scardamaglia L, Morgan V, Kern JS. Australian teledermatology experience during COVID-19. Australas J Dermatol. 2021;62(4):e596–600.
Cowan TL, Ho G, Daniel BS, Murrell DF. Use of a hybrid teledermatology model in an Australian tertiary hospital in the COVID-19 pandemic. JAAD Int. 2023;11:33–4. https://doi.org/10.1016/j.jdin.2022.03.016.
Edwards HA, Shen X, Soyer HP. Teledermatology adaptations in the COVID-19 era. Front Med (Lausanne). 2021;8:675383.
Snoswell CL, Whitty JA, Caffery LJ, Loescher LJ, Gillespie N, Janda M. Direct-to-consumer mobile teledermoscopy for skin cancer screening: preliminary results demonstrating willingness-to-pay in Australia. J Telemed Telecare. 2018;24(10):683–9.
Al-Qirim NA. Teledermatology: the case of adoption and diffusion of telemedicine health Waikato in New Zealand. Telemed J E Health. 2003;9(2):167–77.
Oakley AM, Kerr P, Duffill M, Rademaker M, Fleischl P, Bradford N, Mills C. Patient cost-benefits of realtime teledermatology—A comparison of data from Northern Ireland and New Zealand. J Telemed Telecare. 2000;6(2):97–101.
Oakley AM. Teledermatology in New Zealand. J Cutan Med Surg. 2001;5(2):111–6.
Loane MA, Oakley A, Rademaker M, Bradford N, Fleischl P, Kerr P, Wootton R. A cost-minimization analysis of the societal costs of realtime teledermatology compared with conventional care: results from a randomized controlled trial in New Zealand. J Telemed Telecare. 2001;7(4):233–8.
Oakley AM, Rennie MH. Retrospective review of teledermatology in the Waikato, 1997-2002. Australas J Dermatol. 2004;45(1):23–8.
Oakley A, Rademaker M, Duffill M. Teledermatology in the Waikato region of New Zealand. J Telemed Telecare. 2001;7(Suppl 2):59–61.
Hartvigsen G, Johansen MA, Hasvold P, Bellika JG, Arsand E, Arild E, Gammon D, Pettersen S, Pedersen S. Challenges in telemedicine and eHealth: lessons learned from 20 years with telemedicine in Tromsø. Stud Health Technol Inform. 2007;129(Pt 1):82–6.
Rizvi SMH, Schopf T, Sangha A, Ulvin K, Gjersvik P. Teledermatology in Norway using a mobile phone app. PLoS One. 2020;15(4):e0232131.
Dahl E. Briefing notes on maritime teledermatology. Int Marit Health. 2014;65(2):61–4.
Börve A, Terstappen K, Sandberg C, Paoli J. Mobile teledermoscopy-there’s an app for that! Dermatol Pract Concept. 2013;3(2):41–8.
Schmidt M, Schmidt SAJ, Adelborg K, Sundbøll J, Laugesen K, Ehrenstein V, Sørensen HT. The Danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol. 2019;11:563–91.
Kjærsgaard Andersen R, Jemec GBE. Teledermatology management of difficult-to-treat dermatoses in The Faroe Islands. Acta Dermatovenerol Alp Pannonica Adriat. 2019;28(3):103–5.
Jemec GBE, Heidenheim M, Dam TN, Vang E. Teledermatology on The Faroe Islands. Int J Dermatol. 2008;47:891–3.
Bryld LE, Heidenheim M, Dam TN, Dufour N, Vang E, Agner T, Jemec GB. Teledermatology with an integrated nurse-led clinic on the Faroe Islands—7 years’ experience. J Eur Acad Dermatol Venereol. 2011;25(8):987–90.
Vestergaard T, Andersen MK, Bygum A. Acceptance of teledermoscopy by general practitioners and dermatologists in Denmark. Dermatol Pract Concept. 2021;11(2):e2021033.
Vestergaard T, Prasad SC, Schuster A, Laurinaviciene R, Andersen MK, Bygum A. Diagnostic accuracy and interobserver concordance: teledermoscopy of 600 suspicious skin lesions in Southern Denmark. J Eur Acad Dermatol Venereol. 2020;34(7):1601–8.
Lamminen H, Tuomi ML, Lamminen J, Uusitalo H. A feasibility study of realtime teledermatology in Finland. J Telemed Telecare. 2000;6(2):102–7.
Finch T, Mair F, May C. Teledermatology in the U.K.: lessons in service innovation. Br J Dermatol. 2007;156:521–7.
Mehrtens SH, Shall L, Halpern SM. A 14-year review of a UK teledermatology service: experience of over 40 000 teleconsultations. Clin Exp Dermatol. 2019;44:874–81.
Wootton R, Bloomer SE, Corbett R, Eedy DJ, Hicks N, Lotery HE, et al. Multicentre randomised control trial comparing real time teledermatology with conventional outpatient dermatological care: societal cost-benefit analysis. BMJ. 2000;320:1252.
Loane MA, Corbett R, Bloomer SE, et al. Diagnostic accuracy and clinical management by real-time teledermatology: results from the N Ireland arms of the UK multicentre Teledermatology trial. J Telemed Telecare. 1998;4:95–100.
Loane MA, Bloomer SE, Corbett R, Eedy DJ, Gore HE, Mathews C, Steele K, Wootton R. Patient satisfaction with realtime teledermatology in Northern Ireland. J Telemed Telecare. 1998;4(1):36–40.
Gilmour E, Campbell SM, Loane MA, et al. Comparison of teleconsultations and face-to-face consultations: preliminary results of a U.K. multicentre teledermatology study. Br J Dermatol. 1998;139:81–7.
Elliott LG, Sharma M. Teledermatology 2-week-wait skin cancer referrals during the COVID-19 pandemic: a service evaluation. Clin Exp Dermatol. 2022;47(2):458–9.
Lowe A, Pararajasingam A, Goodwin RG. A paradigm shift in trainee confidence in teledermatology and virtual working during the COVID-19 pandemic: results of a follow-up UK-wide survey. Clin Exp Dermatol. 2021;46(3):544–7.
Hussain K, Patel NP. Fast-tracking teledermatology into dermatology trainee timetables, an overdue necessity in the COVID era and beyond. Clin Exp Dermatol. 2021;46(1):182–3.
Lowe A, Pararajasingam A, Goodwin R. A UK-wide survey looking at teaching and trainee confidence in teledermatology: a vital gap in a COVID-19-induced era of rapid digital transformation? Clin Exp Dermatol. 2020;45(7):876–9.
Cazzaniga S, Castelli E, Di Landro A, Di Mercurio M, Imberti G, Locatelli GA, Raponi F, Vezzoli P, Gambini D, Damiani G, Zucchi A, Naldi L. Mobile teledermatology for melanoma detection: assessment of the validity in the framework of a population-based skin cancer awareness campaign in northern Italy. J Am Acad Dermatol. 2019;81(1):257–60.
Rubegni P, Nami N, Cevenini G, Poggiali S, Hofmann-Wellenhof R, Massone C, Bilenchi R, Bartalini M, Cappelli R, Fimiani M. Geriatric teledermatology: store-and-forward vs. face-to-face examination. J Eur Acad Dermatol Venereol. 2011;25:1334–9.
Cristaudo A, Pigliacelli F, Pacifico A, Damiani G, Iacovelli P, Morrone A. Teledermatology and hygiene practices during the COVID-19 pandemic. Contact Dermatitis. 2020;83(6):536.
Moscarella E, Pasquali P, Cinotti E, Tognetti L, Argenziano G, Rubegni P. A survey on teledermatology use and doctors’ perception in times of COVID-19. J Eur Acad Dermatol Venereol. 2020;34(12):e772–3.
Bergamo S, Calacione R, Fagotti S, Finizio L, Scaini M, Schiesari L, Gatti A. Teledermatology with general practitioners and pediatricians during COVID-19 outbreak in Italy: preliminary data from a second-level dermatology department in North-Eastern Italy. Dermatol Ther. 2020;33(6):e14040.
Brunasso AMG, Massone C. Teledermatologic monitoring for chronic cutaneous autoimmune diseases with smartworking during COVID-19 emergency in a tertiary center in Italy. Dermatol Ther. 2020;33:e13495.
Ruggiero A, Megna M, Annunziata MC, Abategiovanni L, Scalvenzi M, Tajani A, Fabbrocini G, Villani A. Teledermatology for acne during COVID-19: high patients’ satisfaction in spite of the emergency. J Eur Acad Dermatol Venereol. 2020;34(11):e662–3.
Omboni S. Telemedicine during the COVID-19 in Italy: a missed opportunity. Telemed J E Health. 2020;26(8):973–5.
Rosado L et al. Chapter 1 From Dermoscopy to Mobile Teledermatology. 2014.
Costin A, Furtado C. Experience of a Pilot Project of Teledermatology Screening at the Department of Dermatology and Venereology of Hospital Garcia de Orta. J Portug Soc Dermatol Venereol. 2020;77(4):311–4.
de Mello-Sampayo F. Patients’ out-of-pocket expenses analysis of presurgical teledermatology. Cost Eff Resour Alloc. 2019;17:18.
Carvalho R, Morgado AC, Andrade C, Nedelcu T, Carreiro A, Vasconcelos MJM. Integrating domain knowledge into deep learning for skin lesion risk prioritization to assist teledermatology referral. Diagnostics (Basel). 2021;12(1):36.
Moreno-Ramírez D, Argenziano G. Teledermatology and mobile applications in the management of patients with skin lesions. Acta Derm Venereol. 2017;Suppl 218:31–5.
Romero G, de Argila D, Ferrandiz L, Sánchez MP, Vañó S, Taberner R, Pasquali P, de la Torre C, Alfageme F, Malvehy J, Moreno-Ramírez D. Practice models in teledermatology in Spain: longitudinal study, 2009-2014. Actas Dermosifiliogr (Engl Ed). 2018;109(7):624–30.
Vidal-Alaball J, Garcia Domingo JL, Garcia Cuyàs F, Mendioroz Peña J, Flores Mateo G, Deniel Rosanas J, Sauch Valmaña G. A cost savings analysis of asynchronous teledermatology compared to face-to-face dermatology in Catalonia. BMC Health Serv Res. 2018;18(1):650.
López Seguí F, Franch Parella J, Gironès García X, Mendioroz Peña J, García Cuyàs F, Adroher Mas C, García-Altés A, Vidal-Alaball J. A cost-minimization analysis of a medical record-based, store and forward and provider-to-provider telemedicine compared to usual care in Catalonia: more agile and efficient, especially for users. Int J Environ Res Public Health. 2020;17(6):2008.
Barros-Tornay R, Ferrándiz L, Martín-Gutiérrez FJ, Fernández-Orland A, Serrano-Gotarredona A, de la Torre JM, Conejo-Mir MD, Ojeda-Vila T, Márquez-Enríquez J, Hernández C, Ocaña MJ, Herrerías-Esteban JM, Moreno-Ramírez D. Feasibility and cost of a telemedicine-based short-term plan for initial access in general dermatology in Andalusia, Spain. JAAD Int. 2021;4:52–7.
Hungary: Creating an enabling regulation for telemedicine. 31 August 2021. | Meeting report. Download (9.4 MB) WHO Team. Digital Health (DHF) Editors. WHO/Europe. 2021
Jobbágy A, Kiss N, Meznerics FA, Farkas K, Plázár D, Bozsányi S, Fésűs L, Bartha Á, Szabó E, Lőrincz K, Sárdy M, Wikonkál NM, Szoldán P, Bánvölgyi A. Emergency use and efficacy of an asynchronous teledermatology system as a novel tool for early diagnosis of skin cancer during the first wave of COVID-19 pandemic. Int J Environ Res Public Health. 2022;19(5):2699.
Stepaniuk A, Pawlukianiec C, Krawiel M, Lewoc M, Baran A, Flisiak I. Great hopes or disappointment—a survey-based study on patients’ and doctors’ perception of telemedicine during the COVID-19 pandemic in Poland. Postepy Dermatol Alergol. 2022;39(2):384–91.
Ziętek M, Nowacki M, Wierzbicki J, Matkowski R, Maciejczyk A, Czajkowski R, Pawlak-Adamska E. The report and analysis concerning the usefulness of basic telemedicine tools in the skin cancer diagnostic screening process during COVID-19 pandemics. Postepy Dermatol Alergol. 2022;39(1):189–94.
Günter B. Telemedicine and teledermatology. 2003
Tandjung R, Badertscher N, Kleiner N, Wensing M, Rosemann T, Braun RP, Senn O. Feasibility and diagnostic accuracy of teledermatology in Swiss primary care: process analysis of a randomized controlled trial. J Eval Clin Pract. 2015;21(2):326–31.
Markun S, Scherz N, Rosemann T, Tandjung R, Braun RP. Mobile teledermatology for skin cancer screening: a diagnostic accuracy study. Medicine (Baltimore). 2017;96(10):e6278.
Eber EL, Janda M, Arzberger E, Hofmann-Wellenhof R. Survey on the status of teledermatology in Austria. J Dtsch Dermatol Ges. 2019;17:25–31.
Kroemer S, Frühauf J, Campbell TM, Massone C, Schwantzer G, Soyer HP, Hofmann-Wellenhof R. Mobile teledermatology for skin tumour screening: diagnostic accuracy of clinical and dermoscopic image tele-evaluation using cellular phones. Br J Dermatol. 2011;164(5):973–9.
Massone C, Maak D, Hofmann-Wellenhof R, Soyer HP, Frühauf J. Teledermatology for skin cancer prevention: an experience on 690 Austrian patients. J Eur Acad Dermatol Venereol. 2014;28(8):1103–8.
Frühauf J, Kröck S, Quehenberger F, Kopera D, Fink-Puches R, Komericki P, Pucher S, Arzberger E, Hofmann-Wellenhof R. Mobile teledermatology helping patients control high-need acne: a randomized controlled trial. J Eur Acad Dermatol Venereol. 2015;29(5):919–24.
Koller S, Hofmann-Wellenhof R, Hayn D, Weger W, Kastner P, Schreier G, Salmhofer W. Teledermatological monitoring of psoriasis patients on biologic therapy. Acta Derm Venereol. 2011;91(6):680–5.
Frühauf J, Schwantzer G, Ambros-Rudolph CM, Weger W, Ahlgrimm-Siess V, Salmhofer W, Hofmann-Wellenhof R. Pilot study on the acceptance of mobile teledermatology for the home monitoring of high-need patients with psoriasis. Australas J Dermatol. 2012;53(1):41–6.
Kips J, Lambert J, Ongenae K, De Sutter A, Verhaeghe E. Teledermatology in Belgium: a pilot study. Acta Clin Belg. 2020;75(2):116–22.
Damsin T, Canivet G, Jacquemin P, Seidel L, Gillet P, Giet D, Nikkels AF. Value of teledermoscopy in primary healthcare centers: preliminary results of the TELESPOT project in Belgium. Dermatol Ther (Heidelb). 2020;10(6):1405–13.
Thielscher C, Doarn CR. Long-term future of telemedicine in Germany: the patient’s, physician’s, and payer’s perspective. Telemed J E Health. 2008;7:701–6.
Sondermann W, von Kalle C, Utikal JS, et al. Externe wissenschaftliche Evaluation der ersten Teledermatologie-App ohne direkten Patientenkontakt in Deutschland (“Online Hautarzt—AppDoc”). Hautarzt. 2020;71:887–97.
Skayem C, Rostom H, Hirsch G, Duong TA. Teledermatology: the perspective of French general practitioners. Ann Dermatol Venereol. 2021;148(4):251–2.
Bataille M, Mahé E, Dorizy-Vuong V, Skayem C, Dompmartin A, Richard MA, Friedel J, Ottavy F, Gautier MS, Carvalho P, Duong TA, the Groupe de Télé-Dermatologie & e-Santé de la Société Française de Dermatologie (TELDES). French teledermatologists: activity and motivations prior to the COVID-19 pandemic. Acta Derm Venereol. 2021;101(5):adv00467.
Messagier AL, Blaizot R, Couppié P, Delaigue S. Teledermatology use in remote areas of French Guiana: experience from a long-running system. Front Public Health. 2019;7:387.
Skayem C, Hua C, Zehou O, Jannic A, Viarnaud A, Wolkenstein P, Duong TA. Skin cancer and COVID-19: was the diagnosis safeguarded by teledermatology? A study on 1229 cases. J Eur Acad Dermatol Venereol. 2022; https://doi.org/10.1111/jdv.18138.
Brehon A, Shourick J, Hua C, Skayem C, Wolkenstein P, Chosidow O, Duong TA. Dermatological emergency unit, day-care hospital and consultations in time of COVID-19: the impact of teledermatology. J Eur Acad Dermatol Venereol. 2022;36(3):e175–7.
Tensen E, van der Heijden JP, Jaspers MWM, et al. Two decades of teledermatology: current status and integration in National Healthcare Systems. Curr Dermatol Rep. 2016;5:96–104.
Witkamp L, van der Heijden JP. Health management practice as a method to introduce teledermatology: experiences from The Netherlands. In: Soyer H, Binder M, Smith A, Wurm E, editors. Telemedicine in dermatology. Berlin, Heidelberg: Springer; 2012.
van der Heijden JP, de Keizer NF, Bos JD, Spuls PI, Witkamp L. Teledermatology applied following patient selection by general practitioners in daily practice improves efficiency and quality of care at lower cost. Br J Dermatol. 2011;165(5):1058–65.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Ethics declarations
All authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Chen, J., Cai, E.D., Choudhary, S. (2023). Teledermatology: International. In: English III, J.C. (eds) Teledermatology. Updates in Clinical Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-031-27276-9_22
Download citation
DOI: https://doi.org/10.1007/978-3-031-27276-9_22
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-27275-2
Online ISBN: 978-3-031-27276-9
eBook Packages: MedicineMedicine (R0)